Ameren signals 9.2% rate base growth CAGR and $63B investment pipeline through 2029
Q4 2024 Management View CEO Martin Lyons highlighted strong operational and financial results for 2024, including adjusted earnings of $4.63 per share, exceeding the midpoint of their guidance range.
Moderna is counting on its product pipeline to resuscitate its ailing stock
Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...